Opening Asia for Russia

Sputnik Light vaccine registered in Russia

06.05.2021 37 просмотров

The effectiveness of the one-component vaccine was 79.4% from the 28th day after receiving the immunization.


The single-component vaccine against coronavirus Sputnik Light has been registered in Russia, follows from the message of the Russian Direct Investment Fund (RDIF).

Gamaleya and RDIF announce the registration of a one-component Sputnik light vaccine against a new coronavirus infection. The Sputnik Light drug is the first component of the Sputnik V coronavirus vaccine, the message says.

The effectiveness of the single-component Sputnik Light vaccine was 79.4% from the 28th day after receiving immunization. The efficacy rate of about 80% exceeds that of many vaccines that require two shots.

Efficacy was calculated based on data from Russians who received only one shot as part of the mass civilian vaccination program and did not receive a second shot for any reason in the period from December 5, 2020 to April 15, 2021.

The incidence among vaccinated citizens, starting from the 28th day from the date of immunization, was only 0.277%.

Sputnik Light is effective against all new strains of coronavirus based on the results of laboratory studies at the National Research Center for Epidemiology and Microbiology N.F. Gamalei.

Sputnik Light will be exported

According to the head of the RDIF Kirill Dmitriev, quoted in the message, the two-component drug Sputnik V” remains the main tool for vaccination in Russia, while the one-component “Sputnik Light” will be exported to foreign partners and will help speed up vaccination in a number of countries. the likelihood of severe cases of the disease that lead to hospitalization. The one-component scheme of application makes it possible to vaccinate a large number of people in a short time and achieve herd immunity faster. The characteristics of the vaccine ensure ease of storage and logistics, while Sputnik Light has an affordable price of less than $10,” said Kirill Dmitriev.

Новости партнёров